AbbVie (ABBV) Accumulated Expenses (2012 - 2015)

AbbVie has disclosed Accumulated Expenses across 4 years of filings, most recently posting $411.0 million for Q4 2015.

• In Q4 2015, Accumulated Expenses fell 49.94% year-over-year to $411.0 million; the TTM figure through Dec 2015 stood at $411.0 million (down 49.94% YoY), while the FY2015 annual figure was $411.0 million, down 49.94% from the prior year.
• Accumulated Expenses slipped to $411.0 million in Q4 2015, from $821.0 million in the prior quarter.
• Over the last five years, Accumulated Expenses for ABBV reached as high as $821.0 million in Q4 2014 and fell as low as $411.0 million in Q4 2015.
• The 4-year median for Accumulated Expenses is $572.0 million (2012), against an average of $594.0 million.
• Annual changes were most pronounced in 2014 — Accumulated Expenses soared 32.21% — and 2015, when it tumbled 49.94%.
• A 4-year view of Accumulated Expenses shows it stood at $523.0 million in 2012, then grew by 18.74% to $621.0 million in 2013, then soared by 32.21% to $821.0 million in 2014, then plunged by 49.94% to $411.0 million in 2015.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $411.0 million, $821.0 million, and $621.0 million for Q4 2015, Q4 2014, and Q4 2013 respectively.